Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its...

Poster presentation describes potential of oncology programs RBI-1000 and RBI-3000 to target known acquired resistance mutations SAN DIEGO, Oct. 31, 2023 /PRNewswire/ -- Replicate Bioscience, a...

COM503, a potential first-in-class, high affinity anti-IL18 binding protein antibody frees endogenous IL-18 to inhibit cancer growth Anti-IL-18BP antibody immune modulation is confined to the...

In vitro proof-of-concept for novel myeloid and B cell modulating anti-CLEC2D-TLR9 agonist conjugate program, a compelling immunotherapeutic approach to induce T and NK cell recruitment in tumors...

Carrier Global Corporation (NYSE: CARR) Chairman & CEO David Gitlin will speak at the Baird 2023 Global Industrial Conference on Tuesday, Nov. 7, 2023 at 12:25 p.m. ET. The event will be broadcast...